Latest On Silk Road Medical, Inc (SILK):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-28 09:59 EST | News | Silk Road Medical: Speculative Appeal Is Seen Here | N/A |  |
| 2023-05-15 14:49 EST | News | Silk Road Medical downgraded at Wolfe on revised market view | N/A | |
| 2023-05-13 20:31 EST | News | Silk Road Medical, Inc. (SILK) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-09 18:12 EST | News | Silk Road Medical GAAP EPS of -$0.43 misses by $0.05, revenue of $40.13M misses by $0.56M | N/A | |
| 2023-04-01 01:51 EST | News | Silk Road Medical draws Buy at B. Riley on valuation mismatch | N/A | |
About Silk Road Medical, Inc (SILK):
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
General
- Name Silk Road Medical, Inc
- Symbol SILK
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 281
- Fiscal Year EndDecember
- IPO Date2019-04-04
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://silkroadmed.com
Valuation
- Price/Sales (Trailing 12 Mt.) 22.53
- Price/Book (Most Recent Quarter) 16.43
- Enterprise Value Revenue 22.18
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.39
- Next Year EPS Estimate -$0.96
- Next Quarter EPS Estimate -$0.25
- Profit Margin -63%
- Operating Margin -57%
- Return on Assets -17%
- Return on Equity -53%
- Revenue 75.23 million
- Earnings Per Share -$6.30
- Revenue Per Share $2.28
- Gross Profit 53.94 million
- Quarterly Earnings Growth 13.4%
Highlights
- Market Capitalization 1.75 billion
- EBITDA -24408000
- PE Ratio -19.48
- Analyst Target Price $67
- Book Value Per Share $3.14
Share Statistics
- Shares Outstanding 34.37 million
- Shares Float 33.25 million
- % Held by Insiders 277%
- % Held by Institutions 104.52%
- Shares Short 2.82 million
- Shares Short Prior Month 2.84 million
- Short Ratio 8.74
- Short % of Float 10%
- Short % of Shares Outstanding 8%
Technicals
- 52 Week High $75.8
- 52 Week Low $23
- 50 Day Moving Average 55.62
- 200 Day Moving Average 60.53
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Silk Road Medical, Inc (SILK) Dividend Calendar:
Silk Road Medical, Inc (SILK) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Silk Road Medical, Inc (SILK) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Silk Road Medical, Inc (SILK) Chart:
Silk Road Medical, Inc (SILK) News:
Below you will find a list of latest news for Silk Road Medical, Inc (SILK) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Silk Road Medical, Inc (SILK) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest SILK Trades:
Silk Road Medical, Inc (SILK) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-04 | 8-K/A (Current report) | |
| 2020-11-04 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-29 | 8-K (Current report) | |
| 2020-10-16 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-13 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-05 | 3 (Initial statement of beneficial ownership of securities) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-01 | 8-K (Current report) | |
| 2020-09-21 | 8-K (Current report) | |
| 2020-09-18 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-15 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-19 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-17 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-13 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-08-12 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-05 | 8-K (Current report) | |
| 2020-08-04 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-16 | 4 (Statement of changes in beneficial ownership of securities) | |
Silk Road Medical, Inc (SILK) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Silk Road Medical, Inc (SILK). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 277%
Institutional Ownership: 10452%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-11-02 | Andrew S. Davis | Chief Commercial Officer | Sell | 6,640.00 | 61.37 | 407,484.18 | 19,802.00 | |
| 2020-11-02 | Andrew S. Davis | Chief Commercial Officer | Buy | 6,640.00 | 1.46 | 9,694.40 | 26,442.00 | |
| 2020-10-14 | Lucas W. Buchanan | COO/CFO | Sell | 2,729.00 | 65.21 | 177,959.18 | 111,027.00 | |
| 2020-10-14 | Lucas W. Buchanan | COO/CFO | Buy | 2,729.00 | 4.73 | 12,908.17 | 113,756.00 | |
| 2020-10-14 | Lucas W. Buchanan | COO/CFO | Buy | 6,871.00 | 4.73 | 32,499.83 | 117,898.00 | |
| 2020-10-12 | Erica J. Rogers | President and CEO | Sell | 20,044.00 | 66.16 | 1,326,133.09 | 111,608.00 | |
| 2020-10-12 | Erica J. Rogers | President and CEO | Buy | 20,044.00 | 1.46 | 29,264.24 | 131,652.00 | |
| 2020-10-01 | Andrew S. Davis | Chief Commercial Officer | Sell | 6,635.00 | 65.60 | 435,238.75 | 19,802.00 | |
| 2020-10-01 | Andrew S. Davis | Chief Commercial Officer | Buy | 6,635.00 | 1.46 | 9,687.10 | 26,437.00 | |
| 2020-09-17 | Lucas W. Buchanan | Chief Financial Officer | Sell | 9,600.00 | 67.32 | 646,284.48 | 111,027.00 | |
| 2020-09-17 | Lucas W. Buchanan | Chief Financial Officer | Buy | 9,600.00 | 4.73 | 45,408.00 | 120,627.00 | |
| 2020-09-11 | Erica J. Rogers | President and CEO | Sell | 16,374.00 | 60.98 | 998,538.92 | 111,608.00 | |
| 2020-09-11 | Erica J. Rogers | President and CEO | Buy | 476.00 | 1.38 | 656.88 | 112,084.00 | |
| 2020-09-11 | Erica J. Rogers | President and CEO | Buy | 3,194.00 | 1.38 | 4,407.72 | 114,802.00 | |
| 2020-09-11 | Erica J. Rogers | President and CEO | Buy | 16,374.00 | 1.46 | 23,906.04 | 127,982.00 | |
| 2020-09-01 | Andrew S. Davis | Chief Commercial Officer | Sell | 6,635.00 | 59.72 | 396,262.11 | 19,802.00 | |
| 2020-09-01 | Andrew S. Davis | Chief Commercial Officer | Buy | 6,635.00 | 1.46 | 9,687.10 | 26,437.00 | |
| 2020-08-17 | Lucas W. Buchanan | Chief Financial Officer | Sell | 7,279.00 | 53.86 | 392,078.24 | 111,027.00 | |
| 2020-08-17 | Lucas W. Buchanan | Chief Financial Officer | Buy | 2,321.00 | 1.60 | 3,713.60 | 113,348.00 | |
| 2020-08-17 | Lucas W. Buchanan | Chief Financial Officer | Buy | 7,279.00 | 4.73 | 34,429.67 | 118,306.00 | |